Checkpoint Inhibitors and Aspergillosis in AML: the Double Hit Hypothesis
Overview
Authors
Affiliations
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research.
Lewis R J Fungi (Basel). 2024; 10(6).
PMID: 38921367 PMC: 11205125. DOI: 10.3390/jof10060382.
Aerts R, Ricano-Ponce I, Bruno M, Mercier T, Rosati D, Maertens J Mycopathologia. 2024; 189(2):24.
PMID: 38407673 PMC: 10896822. DOI: 10.1007/s11046-024-00831-8.
Wurster S, Watowich S, Kontoyiannis D Front Immunol. 2022; 13:1018202.
PMID: 36389687 PMC: 9640966. DOI: 10.3389/fimmu.2022.1018202.
Wurster S, Albert N, Bharadwaj U, Kasembeli M, Tarrand J, Daver N Front Immunol. 2022; 13:838344.
PMID: 35251033 PMC: 8896628. DOI: 10.3389/fimmu.2022.838344.
Aspergillus fumigatus and Aspergillosis in 2019.
Latge J, Chamilos G Clin Microbiol Rev. 2019; 33(1).
PMID: 31722890 PMC: 6860006. DOI: 10.1128/CMR.00140-18.